Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)

類似資料

• Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
  著者:: Javanmard, Shaghayegh Haghjooy, 等
  出版事項: (2020)
• Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
  著者:: Li, Edmond CK, 等
  出版事項: (2014)
• Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
  著者:: ElAbd, Rawan, 等
  出版事項: (2021)
• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
  著者:: Shrimpton, A.J., 等
  出版事項: (2020)
• Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
  著者:: Wang, Wenjun, 等
  出版事項: (2021)